Strategic Acquisition Aran Biomedical is now part of Integer, positioning it within a large global CDMO network. This suggests opportunities to collaborate on scale-up, regulatory support, and expanded manufacturing capabilities for biomaterial implants across cardiovascular, general surgery, and orthopaedics.

Expansion Momentum Recent growth includes a headcount increase and facility expansion plans in Galway, signaling ongoing capacity enhancement. Sales teams can engage to align client projects with available capacity and upcoming expansion timelines.

Biomaterial Focus Specialization in biomaterial coverings, coatings, and absorbable implants supports selling at the innovation edge for medical devices that require advanced coatings and biocompatible materials, particularly in cardiovascular and orthopaedics.

Contract Manufacturing Aran Biomedical offers end-to-end contract development to finished packaged implants, including concept to production transfer in a quality environment. This presents cross-sell opportunities with device companies seeking turnkey outsourcing plus access to Integer’s global CDMO network.

Strategic Partnerships With a track record of design, development and manufacturing expertise in medical textiles and biomaterial technologies, target collaborations around early-stage product development, regulatory readiness, and scale-up to support clinician-ready, next-generation implants.